Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 30051 - 30075 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Deferoxamine	Approved Investigational	VEGFA	7422	upregulated	Deferoxamine results in increased expression of VEGFA mRNA	6p21.1	A22077 A22071
Prasterone	Approved Investigational Nutraceutical	CDKN1A	1026	upregulated	Dehydroepiandrosterone results in increased expression of CDKN1A mRNA	6p21.2	A22078
Prasterone	Approved Investigational Nutraceutical	CYP17A1	1586	downregulated	Dehydroepiandrosterone results in decreased expression of CYP17A1 mRNA	10q24.32	A21729
Prasterone	Approved Investigational Nutraceutical	CYP1A2	1544	downregulated	Dehydroepiandrosterone results in decreased expression of CYP1A2 mRNA	15q24.1	A22079
Prasterone	Approved Investigational Nutraceutical	ESR1	2099	upregulated	Dehydroepiandrosterone results in increased expression of ESR1 mRNA alternative form	6q25.1-q25.2	A22080
Prasterone	Approved Investigational Nutraceutical	GPER1	2852	upregulated	Dehydroepiandrosterone results in increased expression of GPER1 mRNA	7p22.3	A22080
Prasterone	Approved Investigational Nutraceutical	KLK3	354	upregulated	Dehydroepiandrosterone results in increased expression of KLK3 mRNA	19q13.33	A20590
Prasterone	Approved Investigational Nutraceutical	MIR21	406991	upregulated	Dehydroepiandrosterone results in increased expression of MIR21 mRNA	17q23.1	A22080
Prasterone	Approved Investigational Nutraceutical	MIR22	407004	upregulated	Dehydroepiandrosterone results in increased expression of MIR22 mRNA	17p13.3	A22080
Prasterone	Approved Investigational Nutraceutical	MIR22	407004	downregulated	[Dehydroepiandrosterone results in increased expression of MIR22 mRNA] which results in decreased expression of PDCD4 protein	17p13.3	A22080
Prasterone	Approved Investigational Nutraceutical	MIRLET7D	406886	upregulated	Dehydroepiandrosterone results in increased expression of MIRLET7D mRNA	9q22.32	A22080
Prasterone	Approved Investigational Nutraceutical	NPPB	4879	downregulated	Dehydroepiandrosterone results in decreased expression of NPPB mRNA	1p36.22	A22082
Prasterone	Approved Investigational Nutraceutical	PDCD4	27250	downregulated	Dehydroepiandrosterone results in decreased expression of PDCD4 mRNA	10q25.2	A22080
Prasterone	Approved Investigational Nutraceutical	TP53	7157	upregulated	Dehydroepiandrosterone results in increased expression of TP53 mRNA	17p13.1	A22078
Prasterone	Approved Investigational Nutraceutical	VMP1	81671	upregulated	Dehydroepiandrosterone results in increased expression of VMP1 mRNA	17q23.1	A22080
Prostaglandin D2	Experimental	PPARGC1A	10891	upregulated	Prostaglandin D2 results in increased expression of PPARGC1A mRNA	4p15.2	A20470
Dronabinol	Approved Illicit Investigational	ABCC12	94160	upregulated	Dronabinol results in increased expression of ABCC12 mRNA	16q12.1	A22083
Dronabinol	Approved Illicit Investigational	ABRACL	58527	upregulated	Dronabinol results in increased expression of ABRACL mRNA	6q24.1	A22083
Dronabinol	Approved Illicit Investigational	ACSL4	2182	upregulated	Dronabinol results in increased expression of ACSL4 mRNA	Xq23	A22084
Dronabinol	Approved Illicit Investigational	ACTR1A	10121	downregulated	Dronabinol results in decreased expression of ACTR1A mRNA	10q24.32	A22083
Dronabinol	Approved Illicit Investigational	ACVR2B	93	upregulated	Dronabinol results in increased expression of ACVR2B mRNA	3p22.2	A22085
Dronabinol	Approved Illicit Investigational	ADGRE5	976	upregulated	Dronabinol results in increased expression of ADGRE5 mRNA	19p13.12	A22086
Dronabinol	Approved Illicit Investigational	AGO1	26523	upregulated	Dronabinol results in increased expression of AGO1 mRNA	1p34.3	A22085
Dronabinol	Approved Illicit Investigational	AGO2	27161	upregulated	Dronabinol results in increased expression of AGO2 mRNA	8q24.3	A22085
Dronabinol	Approved Illicit Investigational	AIMP2	7965	upregulated	Dronabinol results in increased expression of AIMP2 mRNA	7p22.1	A22083

Displaying entries 30051 - 30075 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability